TrialNature medicine2019

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.

Antoni Ribas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.